RecruitingPhase 2NCT06262048

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial

Prevention of Post Operative Urinary Retention After Thoracic Surgery: A Phase II Feasbility Trial


Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Enrollment

60 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objectives of this study are to determine the feasibility of conducting a full-scale randomized control trial comparing the efficacy of tamsulosin compared to placebo in reducing post-operative urinary retention in people undergoing elective thoracic surgery.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called Tamsulosin Hydrochloride for people with urinary retention postoperative. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTamsulosin Hydrochloride

2 days pre-op, day of surgery, 2 days post-op

OTHERPlacebo

2 days pre-op, day of surgery, 2 days post-op


Locations(1)

London Health Sciences Centre

London, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06262048


Related Trials